Hjem › Diffust stort B-celle lymfom › Texas › Dallas
Diffust stort B-celle lymfom kliniske forsøg i Dallas, TX
13 studier for Diffust stort B-celle lymfom søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekruttererFase 2
- Texas Oncology - Dallas Fort Worth, Dallas
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
RekruttererFase 3
- Texas Oncology - DFW ( Site 8000), Dallas
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RekruttererFase 2
- UT Southwestern Medical Center ( Site 0190), Dallas
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekruttererFase 1
- University of Texas Southwestern, Dallas
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Baylor University Medical Center, Dallas
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekruttererObservationsstudie
- UT Southwestern Medical Center, Dallas
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- UT Southwestern Medical Center, Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
RekruttererFase 2
- University of Texas Southwestern Medical Center, Dallas
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
RekruttererFase 1/2
- University of Texas Southwestern Medical Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekruttererFase 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- University of Texas Southwestern Medical Center, Dallas
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
RekruttererFase 1/2
- UT Southwestern Medical Center, Dallas
Diffust stort B-celle lymfom forsøg i andre byer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Chicago, IL18 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Seattle, WA12 studier
Andre studier i Dallas
- Brystkræft55 studier
- Ikke-småcellet lungecancer52 studier
- Metastatisk cancer42 studier
- Hjertesvigt42 studier
- Kræft (alle typer)37 studier
- Prostatakræft36 studier
- Colorektal kræft33 studier
- Overvægt30 studier
- Ægstockræft28 studier
- Blærecancer27 studier
- Lungecancer27 studier
- Livmoderslimhindekræft24 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.